Hepatitis C

"Hepatitis C" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure, which enables searching at various levels of specificity.

MeSH information

Definition | Details | More General Concepts | Related Concepts | More Specific Concepts

INFLAMMATION of the LIVER in humans caused by HEPATITIS C VIRUS, a single-stranded RNA virus. Its incubation period is 30-90 days. Hepatitis C is transmitted primarily by contaminated blood parenterally, and is often associated with transfusion and intravenous drug abuse. However, in a significant number of cases, the source of hepatitis C infection is unknown.

Descriptor ID	D006526
MeSH Number(s)	C02.440.440 C02.782.350.350 C06.552.380.705.440
Concept/Terms	Hepatitis C Hepatitis C Parenterally-Transmitted Non-A, Non-B Hepatitis Parenterally Transmitted Non A, Non B Hepatitis PT-NANBH Hepatitis, Viral, Non-A, Non-B, Parenterally-Transmitted

Below are MeSH descriptors whose meaning is more general than "Hepatitis C".

Diseases [C]
Virus Diseases [C02]
Hepatitis, Viral, Human [C02.440]
Hepatitis C [C02.440.440]
RNA Virus Infections [C02.782]
Flaviviridae Infections [C02.782.350]
Hepatitis C [C02.782.350.350]
Digestive System Diseases [C06]
Liver Diseases [C06.552]
Hepatitis [C06.552.380]
Hepatitis, Viral, Human [C06.552.380.705]
Hepatitis C [C06.552.380.705.440]

Below are MeSH descriptors whose meaning is related to "Hepatitis C".

Below are MeSH descriptors whose meaning is more specific than "Hepatitis C".

Hepatitis C
Hepatitis C, Chronic

publications

Timeline | Most Recent

This graph shows the total number of publications written about "Hepatitis C" by people in this website by year, and whether "Hepatitis C" was a major or minor topic of these publications.

Bar chart showing 282 publications over 30 distinct years, with a maximum of 21 publications in 2017

To see the data from this visualization as text, click here.

Year	Major Topic	Minor Topic	Total
1990	1	0	1
1992	3	1	4
1993	1	0	1
1994	1	2	3
1995	3	1	4
1996	2	0	2
1997	5	1	6
1998	1	0	1
1999	1	2	3
2000	4	0	4
2001	2	2	4
2002	9	0	9
2003	8	4	12
2004	11	1	12
2005	11	0	11
2006	9	5	14
2007	4	4	8
2008	7	4	11
2009	14	4	18
2010	10	5	15
2011	11	1	12
2012	13	2	15
2013	8	5	13
2014	13	1	14
2015	12	2	14
2016	12	2	14
2017	19	2	21
2018	13	2	15
2019	16	3	19
2020	2	0	2

Below are the most recent publications written about "Hepatitis C" by people in Profiles.

Hosry J, Miranda RN, Samaniego F, Angelidakis G, Torres HA. Clinicopathologic characteristics of follicular lymphoma in hepatitis C virus-infected patients. Hematol Oncol. 2020 Aug; 38(3):301-308.

View in: PubMed
So-Armah KA, Lim JK, Lo Re V, Tate JP, Chang CH, Butt AA, Gibert CL, Rimland D, Marconi VC, Goetz MB, Ramachandran V, Brittain E, Long M, Nguyen KL, Rodriguez-Barradas MC, Budoff MJ, Tindle HA, Samet JH, Justice AC, Freiberg MS. FIB-4 stage of liver fibrosis is associated with incident heart failure with preserved, but not reduced, ejection fraction among people with and without HIV or hepatitis C. Prog Cardiovasc Dis. 2020 Mar - Apr; 63(2):184-191.

View in: PubMed
Murag S, Dennis BB, Kim D, Ahmed A, Cholankeril G. Recent advances in liver transplantation with HCV seropositive donors. F1000Res. 2019; 8.

View in: PubMed
Frigeni M, Besson C, Visco C, Fontaine H, Goldaniga M, Visentini M, Pulsoni A, Torres HA, Peveling-Oberhag J, Rossotti R, Zaja F, Rigacci L, Merli M, Dorival C, Alric C, Piazza F, Gentile M, Ferrari A, Pirisi M, Nassi L, Rattotti S, Frustaci A, Milella M, Cencini E, Defrancesco I, Ferretti VV, Bruno R, Hermine O, Arcaini L. Interferon-free compared to interferon-based antiviral regimens as first-line therapy for B-cell lymphoproliferative disorders associated with hepatitis C virus infection. Leukemia. 2020 05; 34(5):1462-1466.

View in: PubMed
Tian T, Huang P, Wu J, Wang C, Fan H, Zhang Y, Yu R, Wu C, Xia X, Fu Z, Li J, Yue M. CD40 polymorphisms were associated with HCV infection susceptibility among Chinese population. BMC Infect Dis. 2019 Oct 15; 19(1):840.

View in: PubMed
Jiang W, Zhuo L, Wu X, Shen J, Ye X, Wang Y, Xia X, Chen H, Yu R, Yang S, Huang P. Association of rs2111485 and rs1990760 Polymorphisms of Interferon Induced with Helicase C Domain 1 Gene with Hepatitis C Virus Clearance in Chinese Han Population. Viral Immunol. 2019 10; 32(8):341-347.

View in: PubMed
Shahani L, Breaux K, Lin M, Marcelli M, Rodriguez-Barradas MC. Veterans Aging Cohort Study Index as a Marker of Bone Disease in HIV-Infected Patients. AIDS Res Hum Retroviruses. 2019 Nov/Dec; 35(11-12):1143-1147.

View in: PubMed
Abe CM, Aguwa M, Zhao M, Sullivan J, Porsa E, Nijhawan AE. Hepatitis C Virus Infection in the Dallas County Jail: Implications for Screening, Prevention, and Linkage to Care. Public Health Rep. 2019 Nov/Dec; 134(6):626-633.

View in: PubMed
Yang JJ, Fan HZ, Tian T, Wu MP, Xie CN, Huang P, Yu RB, Yi HG, Zhang Y, Wang J. Impact of CYP2R1, CYP27A1 and CYP27B1 genetic polymorphisms controlling vitamin D metabolism on susceptibility to hepatitis C virus infection in a high-risk Chinese population. Arch Virol. 2019 Dec; 164(12):2909-2918.

View in: PubMed
Edelman EJ, Maisto SA, Hansen NB, Cutter CJ, Dziura J, Deng Y, Fiellin LE, O'Connor PG, Bedimo R, Gibert CL, Marconi VC, Rimland D, Rodriguez-Barradas MC, Simberkoff MS, Tate JP, Justice AC, Bryant KJ, Fiellin DA. Integrated stepped alcohol treatment for patients with HIV and liver disease: A randomized trial. J Subst Abuse Treat. 2019 11; 106:97-106.

View in: PubMed

People

Explore

Similar Concepts

Top Journals